Mr. Kim brings over 28 years of experience in healthcare investment and biotech corporate executive roles. He has founded both Forward Equity Partners and Medivate Partners – during which he led 15 cross-border PE & VC investments in the US & EU. Previously, Mr. Kim served as the Head of Novartis Venture Fund Korea (NVFK) – first global pharmaceutical fund to focus solely on innovative Asian biotech investments. Before Novartis, Mr. Kim served as co-founder and head of POSCO BioVentures – $62M Venture Fund focused on US & EU biotech investments on behalf of POSCO, $40B steel conglomerate. He has most recently served on the Boards of WCCT Global (acquired by Novo/Altasciences) and Genopis (acquired by Wacker).
Mr. Kim received his bachelor’s degree in Molecular Cell Biology from U.C. Berkeley and is a graduate of Life Sciences Executive program.